Logo image of EMEIS.PA

EMEIS SA (EMEIS.PA) Stock Price, Quote, News and Overview

EPA:EMEIS - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR

12.234  +0.22 (+1.8%)

EMEIS.PA Quote, Performance and Key Statistics

EMEIS SA

EPA:EMEIS (3/7/2025, 7:00:00 PM)

12.234

+0.22 (+1.8%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Facilities
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap1.98B
Shares161.44M
Float108.47M
Yearly Dividend0
Dividend YieldN/A
PE2.49
Fwd PEN/A
Earnings (Next)05-12 2025-05-12
IPO04-16 2002-04-16


EMEIS.PA short term performance overview.The bars show the price performance of EMEIS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

EMEIS.PA long term performance overview.The bars show the price performance of EMEIS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of EMEIS.PA is 12.234 EUR. In the past month the price increased by 55.59%.

EMEIS SA / EMEIS Daily stock chart

EMEIS.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Facilities" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CLARI.PA CLARIANE SE N/A 1.32B
GDS.PA RAMSAY GENERALE DE SANTE SA N/A 1.15B
RHK.DE RHOEN-KLINIKUM AG 19.25 863.78M
GHC.MI GAROFALO HEALTH CARE SPA 13.08 448.29M
M12.DE M1 KLINIKEN AG 17.41 290.67M
LNA.PA LNA SANTE 11.32 283.81M
MED.DE MEDICLIN AG N/A 136.80M
LIK.DE LIMES SCHLOSSKLINIKEN AG N/A 83.52M
EIF.DE MEDNATION AG 1.32 4.21M

About EMEIS.PA

Company Profile

EMEIS logo image Emeis SA is a FR-based company operating in Health Care Providers & Services industry. The company is headquartered in Puteaux, Ile-De-France and currently employs 78,476 full-time employees. The company went IPO on 2002-04-16. Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services, and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.

Company Info

EMEIS SA

12 Rue Jean Jaures, Puteaux Cedex

Puteaux ILE-DE-FRANCE FR

Employees: 78476

Company Website: https://www.emeis.fr/

Investor Relations: http://www.orpea-corp.com/index.php/actionnaire-menu/bourse

Phone: 33140781515

EMEIS SA / EMEIS.PA FAQ

What is the stock price of EMEIS SA today?

The current stock price of EMEIS.PA is 12.234 EUR. The price increased by 1.8% in the last trading session.


What is the ticker symbol for EMEIS SA stock?

The exchange symbol of EMEIS SA is EMEIS and it is listed on the Euronext Paris - Matif exchange.


On which exchange is EMEIS.PA stock listed?

EMEIS.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for EMEIS SA stock?

11 analysts have analysed EMEIS.PA and the average price target is 10.2 EUR. This implies a price decrease of -16.63% is expected in the next year compared to the current price of 12.234. Check the EMEIS SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EMEIS SA worth?

EMEIS SA (EMEIS.PA) has a market capitalization of 1.98B EUR. This makes EMEIS.PA a Small Cap stock.


How many employees does EMEIS SA have?

EMEIS SA (EMEIS.PA) currently has 78476 employees.


Is EMEIS SA (EMEIS.PA) expected to grow?

The Revenue of EMEIS SA (EMEIS.PA) is expected to grow by 8.21% in the next year. Check the estimates tab for more information on the EMEIS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EMEIS SA (EMEIS.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EMEIS SA (EMEIS.PA) stock pay dividends?

EMEIS.PA does not pay a dividend.


When does EMEIS SA (EMEIS.PA) report earnings?

EMEIS SA (EMEIS.PA) will report earnings on 2025-05-12.


What is the Price/Earnings (PE) ratio of EMEIS SA (EMEIS.PA)?

The PE ratio for EMEIS SA (EMEIS.PA) is 2.49. This is based on the reported non-GAAP earnings per share of 4.92 and the current share price of 12.234 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EMEIS.PA.


EMEIS.PA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to EMEIS.PA.


Chartmill TA Rating
Chartmill Setup Rating

EMEIS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to EMEIS.PA. EMEIS.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EMEIS.PA Financial Highlights

Over the last trailing twelve months EMEIS.PA reported a non-GAAP Earnings per Share(EPS) of 4.92. The EPS increased by 220.29% compared to the year before.


Industry RankSector Rank
PM (TTM) 27.04%
ROA 10.61%
ROE 76.36%
Debt/Equity 4.15
Chartmill High Growth Momentum
EPS Q2Q%-360.92%
Sales Q2Q%9.16%
EPS 1Y (TTM)220.29%
Revenue 1Y (TTM)10.24%

EMEIS.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to EMEIS.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 98.31% and a revenue growth 8.21% for EMEIS.PA


Ownership
Inst Owners55.18%
Ins Owners0.81%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target10.2 (-16.63%)
EPS Next Y98.31%
Revenue Next Year8.21%